Literature DB >> 18356745

Elevated erythropoietin mRNA and protein concentrations in the developing human eye.

Shrena Patel1, Michael J Rowe, Sally A Winters, Robin K Ohls.   

Abstract

Erythropoietin (Epo) is an erythropoietic, neurotropic, and angiogenic factor, and may be involved in retinal development. Studies in adult diabetic retinopathy patients reveal significantly elevated vitreal Epo concentrations. It is unknown whether Epo plays a similar role in retinopathy of prematurity. We sought to determine whether Epo is present in the normally developing human eye. Fetal serum and vitreous samples were obtained from 12 to 24 wk gestation. RNA was extracted from isolated retina for Epo mRNA and hypoxia inducible factor-1alpha (HIF) mRNA determination by real-time polymerase chain reaction. Fetal serum was isolated from the umbilical cord. Serum and vitreous samples were analyzed for Epo protein by enzyme-linked immunosorbent serologic assay. In fetal retina, Epo mRNA increased with increasing gestational age, while HIF mRNA remained constant. Epo protein increased with increasing gestation in both vitreous and serum. At each gestational group measured (12-14, 15-17, 18-20, and 21-24 wk), Epo concentrations were significantly greater in vitreous than in serum (p < 0.05). Epo mRNA and protein concentrations increase with increasing gestational age and are greater in the vitreous than serum. We speculate that changes in Epo production following preterm delivery might affect retinal vascular development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18356745     DOI: 10.1203/PDR.0b013e318165b8d1

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

Review 1.  Mediators of ocular angiogenesis.

Authors:  Yureeda Qazi; Surekha Maddula; Balamurali K Ambati
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

2.  The effect of erythropoietin on the severity of retinopathy of prematurity.

Authors:  Y Kandasamy; P Kumar; L Hartley
Journal:  Eye (Lond)       Date:  2014-04-25       Impact factor: 3.775

3.  Safety and efficacy of intravitreal injection of recombinant erythropoietin for protection of photoreceptor cells in a rat model of retinal detachment.

Authors:  Z Xie; F Chen; X Wu; C Zhuang; J Zhu; J Wang; H Ji; Y Wang; X Hua
Journal:  Eye (Lond)       Date:  2011-10-21       Impact factor: 3.775

Review 4.  [Pathogenesis of retinopathy of prematurity].

Authors:  M Heckmann
Journal:  Ophthalmologe       Date:  2008-12       Impact factor: 1.059

Review 5.  Revisiting the role of erythropoietin for treatment of ocular disorders.

Authors:  S L Shirley Ding; S N Leow; R Munisvaradass; E H Koh; M L C Bastion; K Y Then; S Kumar; P L Mok
Journal:  Eye (Lond)       Date:  2016-06-10       Impact factor: 3.775

6.  VEGF mRNA and protein concentrations in the developing human eye.

Authors:  Irene T Ma; Suzanne McConaghy; Kopperuncholan Namachivayam; Brian A Halloran; Ashish R Kurundkar; Krishnan MohanKumar; Akhil Maheshwari; Robin K Ohls
Journal:  Pediatr Res       Date:  2015-01-14       Impact factor: 3.756

7.  Mitigation of Sodium Iodate-Induced Cytotoxicity in Retinal Pigment Epithelial Cells in vitro by Transgenic Erythropoietin-Expressing Mesenchymal Stem Cells.

Authors:  Avin Ee-Hwan Koh; Suresh Kumar Subbiah; Aisha Farhana; Mohammad Khursheed Alam; Pooi Ling Mok
Journal:  Front Cell Dev Biol       Date:  2021-04-15

8.  Erythropoietin in brain development and beyond.

Authors:  Mawadda Alnaeeli; Li Wang; Barbora Piknova; Heather Rogers; Xiaoxia Li; Constance Tom Noguchi
Journal:  Anat Res Int       Date:  2012-02-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.